This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Corbus Pharmaceuticals Holdings' financial position is stable for now, with about two years of cash runway. Click here to ...

Follistatin-344 peptide has garnered significant attention in scientific research due to its intricate interactions with ...

Follistatin-344 (FS-344), a glycoprotein variant, has emerged as a focal point in scientific research due to its potential ...

Concludes Strategic Alternatives Review and Provides Update on Development of KER-065LEXINGTON, Mass., June 09, 2025 (GLOBE ...

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

TGF-beta signaling also controls vascular development, with loss-of-function mutations in TGF-beta receptor 1 (TGFBR1/ALK5), TGFBR2, the EC accessory receptor Endoglin, or various SMADs producing ...

Endothelial cell-specific loss of TGF-beta signaling in mice leads to CNS vascular defects, specifically impairing retinal development and promoting immune cell infiltration. The data are solid, ...

Why context is key for TGF-Beta's role in cancer metastasis. The study brings together two longstanding areas of research for the Massagué Lab: TGF-beta signaling and metastasis.

Dr. Massagué, who is Director of the Sloan Kettering Institute as well as MSK’s Chief Scientific Officer, is known for his pioneering work that uncovered the mechanism of action for transforming ...